Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Not applicableStudy completedNCT00463008
What this trial is testing

Pharmacologic Study of Methotrexate in Patients Undergoing Stereotactic Biopsy for Recurrent High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium 12
Early research (Phase 1)Looking for participantsNCT05629689
What this trial is testing

Evaluate GEH200520/GEH200521 (18F) Safety and Tolerability When Used for PET Scans in Patients With Solid Tumour Malignancies

Who this might be right for
Malignant Solid TumorOncology
GE Healthcare 50
Testing effectiveness (Phase 2)Looking for participantsNCT07462650
What this trial is testing

Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticAdenocarcinoma of Colon
Beijing Biotech 48
Not applicableUnknownNCT02891291
What this trial is testing

Optical Tomographic Scanner for Skin Lesions

Who this might be right for
Skin Cancer, Benign Skin Tumor, Inflammatory Skin Disease
National Taiwan University Hospital 300
Not applicableLooking for participantsNCT06728891
What this trial is testing

Analysis of Tumor Deposit at the Fusion Site of the Right Gastric Mesentery and Left Gastric Mesentery in the Patients With Gastric Cancer Who Received Proximal Gastrectomy

Who this might be right for
Gastric Carcinoma
Jichao Qin 100
Testing effectiveness (Phase 2)WithdrawnNCT02973191
What this trial is testing

Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Celgene
Testing effectiveness (Phase 2)WithdrawnNCT03166176
What this trial is testing

Phase II Trial of Vistusertib（AZD2014） Single Agent in TSC1or 2 Null or TSC 1/2 Mutation Solid Cancer Patients Refractory to Standard Chemotherapy

Who this might be right for
Solid Tumor
Samsung Medical Center
Very early researchUnknownNCT05239676
What this trial is testing

Autologous Hematopoietic Stem Cell Transplantation Combined With CAR-T Cells in the Treatment of Refractory and Relapsed Malignant Lymphoma

Who this might be right for
Lymphoma
Zhejiang University 50
Not applicableStudy completedNCT02785289
What this trial is testing

A Comparison of Cotton and Flocked Swabs for Vaginal Self Collection

Who this might be right for
Human Papillomavirus Infection
University Hospital, Geneva 120
Very early researchEnded earlyNCT04150874
What this trial is testing

Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
H. Lee Moffitt Cancer Center and Research Institute 4
Not applicableStudy completedNCT01627990
What this trial is testing

Nivestim™ in Treatment of Malignant Diseases

Who this might be right for
Solid TumourMalignant Haematological TumourPrimary or Secondary Prophylactic Treatment
Hospira, now a wholly owned subsidiary of Pfizer 386
Early research (Phase 1)Looking for participantsNCT07107490
What this trial is testing

A PHASE I STUDY OF ALPS12 IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Chugai Pharmaceutical 122
Not applicableActive Not RecruitingNCT06664190
What this trial is testing

Pre-operative Surgical Difficulty Stratification Using Predicted Tumor Perfusion and Consistency

Who this might be right for
Pituitary Adenoma
Huashan Hospital 200
Not applicableStudy completedNCT00185913
What this trial is testing

Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers

Who this might be right for
Lung Cancer
Stanford University 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT02498613
What this trial is testing

Cediranib in Combination With Olaparib in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Lung Small Cell Carcinoma+23 more
National Cancer Institute (NCI) 122
Not applicableStudy completedNCT05478018
What this trial is testing

Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus ErythematosusInterferon Deficiency
Rigshospitalet, Denmark 55
Testing effectiveness (Phase 2)WithdrawnNCT06090318
What this trial is testing

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

Who this might be right for
Advanced Solid TumorCDKN2ANSCLC+7 more
Rain Oncology Inc
Not applicableStudy completedNCT04796090
What this trial is testing

Genital Wart and Sexuality in Adolescence

Who this might be right for
Adolescent DevelopmentGenital WartSexual Dysfunction+1 more
Ankara City Hospital Bilkent 90
Early research (Phase 1)Looking for participantsNCT07755397
What this trial is testing

First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor

Who this might be right for
NSCLC Patients With EGFR Activating MutationAdenoid Cystic Carcinoma MetastaticAdenoid Cystic Carcinoma of the Head and Neck
Jubilant Therapeutics India Limited 30
Next Page